HIGHLIGHTS
- who: Jean-Philippe Miron from the en Neurosciences de Lyon, France University of Nicosia, Cyprus have published the research work: Transcranial magnetic stimulation and intravenous ketamine combination therapy for treatment-resistant bipolar depression: A case report, in the Journal: (JOURNAL)
SUMMARY
Despite the available first-line therapies for major depression, around 1/3 of patients will develop treatment-resistant depression (TRD). Of note during this phase of treatment was that the patient remained on 3 mg of clonazepam per day throughout treatment, which he was unable to wean off because of crippling anxiety . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.